T2D Excellence Forum

In this video, Angela Golden, DNP, FNP-C, discusses evidence-based approaches in the management of patients with obesity, including the use of medications, surgery, and controversies. 

In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with...

In this podcast, Diana Isaacs, PharmD, CDCES, talks about continuous glucose monitoring (CGM) technology and how it can be used for medicine adjustments and lifestyle interventions for patients with...

In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about how clinicians can individualize care for their patients with type 2 diabetes, including strategies that can be used, what...

In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...

In their single-center study, Viral Shah, MD, and his research team analyzed the association between diabetes technology use and mean clinic hemoglobin A1C among adults with type 1 diabetes.

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...